These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2843324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.
    Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F.
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):433-4. PubMed ID: 3137055
    [No Abstract] [Full Text] [Related]

  • 4. Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
    Bingen E, Bourgeois F, Chardon H, Doit C, Lambert-Zechovsky N.
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):923-6. PubMed ID: 1486888
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J, Escoubas J, Fouche J, Mormede M.
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [Abstract] [Full Text] [Related]

  • 9. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K, Jakoniuk P, Sacha PT, Zalewska M, Wieczorek P.
    Med Dosw Mikrobiol; 2004 May; 56(3):231-7. PubMed ID: 15773499
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
    Fernández-Roblas R, Jiménez Arriero M, Rodriguez-Tudela JL, Soriano F.
    J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
    [Abstract] [Full Text] [Related]

  • 14. Exacerbation of COPD: amoxicillin + clavulanic acid in vitro activity vs S. pneumoniae, H. influenzae and M. catarrhalis.
    Beghi G, Legnani D, De Bartolo A, Pagani N, Lusco G.
    J Chemother; 1995 Nov; 7 Suppl 4():61-2. PubMed ID: 8904109
    [No Abstract] [Full Text] [Related]

  • 15. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO, Gezelius L.
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [Abstract] [Full Text] [Related]

  • 16. [Measure by turbidimetry and bactericidal effect of the speed of action of clavulanic acid, amoxicillin and their combinations on a Haemophilus influenzae producer of beta-lactamase].
    Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.
    Pathol Biol (Paris); 1987 May; 35(5):526-30. PubMed ID: 3302856
    [Abstract] [Full Text] [Related]

  • 17. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
    Credito KL, Lin G, Pankuch GA, Bajaksouzian S, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2001 Jan; 45(1):67-72. PubMed ID: 11120946
    [Abstract] [Full Text] [Related]

  • 18. [In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)].
    Deguchi K, Fukayama S, Nishimura Y, Yokota N, Tanaka S, Oda S, Matsumoto Y, Ikegami R, Sato K, Fukumoto T.
    Jpn J Antibiot; 1985 Oct; 38(10):2797-808. PubMed ID: 3878415
    [Abstract] [Full Text] [Related]

  • 19. The influence of culture medium on the comparative in-vitro activity of amoxycillin and amoxycillin/clavulanic acid against Branhamella catarrhalis.
    Soriano F, Jiménez-Arriero M, Fernández-Roblas R.
    J Antimicrob Chemother; 1987 Aug; 20(2):285-6. PubMed ID: 3117763
    [No Abstract] [Full Text] [Related]

  • 20. Bactericidal effects of co-amoxiclav (amoxycillin clavulanic acid) against a Legionella pneumophila pneumonia in the immunocompromised weanling rat.
    Smith GM, Abbott KH, Sutherland R.
    J Antimicrob Chemother; 1992 Oct; 30(4):525-34. PubMed ID: 1490922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.